feed,title,long_url,short_url
Benzinga,Iovance Biotherapeutics Announces 33-Month Follow Up Data for Lifileucel in Advanced Melanoma at ASCO 2021 Annual Meeting,https://benzinga.com/node/21442875,https://j.mp/3pxCAU3
